where to next?, page-48

its a fair call to make if we are only looking at the short term here. Thats why we have gone into JV in chile where we have already harvested the first 2 crops. Those crops are also growing and achieving a better "grade" of the final "material". Dont forget that we currently have just under $40 million in the bank and our cash burn is fairly low. We have all the necessary licenses in place, we are already expecting to release our own proprietary cannabinoid capsules to world markets (after our own “successful” pilot study into its optimum final dose) in mid 2019. Revenue is coming and it will be a significant one. Those who see the AC8 as the long term investment will be rewarded. Personally I prefer for AC8 to progress into the market on its own merit of the development as we have already seen that they always do what they say they will do. The future is bright for all AC8 holders. Day traders will always be there and the SP will be moving back and forth depending on the future company developments but one thing is for sure- once the revenue starts coming in the SP will be going only one way- UP. (IMO)